Cargando…
Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
Neuroprotection has proven clinically unsuccessful in subarachnoid hemorrhage. We believe that this is because the major component in the early damage pathway, the vascular wall, has not been given the necessary focus. U0126 is a potent inhibitor of vascular phenotypical changes, exemplified by func...
Autores principales: | Christensen, S. T., Grell, A. S., Johansson, S. E., Andersson, C. M., Edvinsson, L., Haanes, K. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691891/ https://www.ncbi.nlm.nih.gov/pubmed/31274009 http://dx.doi.org/10.1080/10717544.2019.1636421 |
Ejemplares similares
-
MEK1/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats
por: Christensen, Simon T., et al.
Publicado: (2019) -
U0126: Not only a MAPK kinase inhibitor
por: You, Yijie, et al.
Publicado: (2022) -
Effects of Cremophor EL on distribution of Taxol to serum lipoproteins.
por: Sykes, E., et al.
Publicado: (1994) -
The MEK Inhibitor Trametinib Improves Outcomes following Subarachnoid Haemorrhage in Female Rats
por: Bömers, Jesper Peter, et al.
Publicado: (2022) -
The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance.
por: Schuurhuis, G. J., et al.
Publicado: (1990)